Sarah Hindmarch
Overview
Explore the profile of Sarah Hindmarch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hindmarch S, Gorman L, Usher-Smith J, Woof V, Howell S, French D
PLoS One
. 2024 Sep;
19(9):e0308638.
PMID: 39269936
Background: Identifying women aged 30-39 years at increased risk of developing breast cancer would allow them to receive screening and prevention offers. For this to be feasible, the practicalities of...
2.
Long H, Hindmarch S, Martindale J, Brooks J, Harvie M, French D
Psychooncology
. 2024 Mar;
33(4):e6334.
PMID: 38549216
Objective: (i) To systematically identify constructs and outcome measures used to assess the emotional and mood impact of false positive breast screening test results; (ii) to appraise the reporting clarity...
3.
Hindmarch S, Howell S, Usher-Smith J, Gorman L, Evans D, French D
BMJ Open
. 2024 Jan;
14(1):e078555.
PMID: 38199637
Introduction: Breast cancer incidence starts to increase exponentially when women reach 30-39 years, hence before they are eligible for breast cancer screening. The introduction of breast cancer risk assessment for...
4.
Hindmarch S, Gorman L, Hawkes R, Howell S, French D
BMC Womens Health
. 2023 Jun;
23(1):312.
PMID: 37328760
Background: Younger women are often diagnosed with advanced breast cancer. Beliefs about risk are instrumental in motivating many health protective behaviours, but there may be confusion around which behaviour is...
5.
Hindmarch S, Gorman L, Hawkes R, Howell S, French D
Womens Health (Lond)
. 2023 Mar;
19:17455057231160348.
PMID: 36999304
Background: Identifying women aged 30-39 years at increased risk of developing breast cancer could allow them to consider screening and preventive strategies. Research is underway to determine the feasibility of...
6.
Usher-Smith J, Hindmarch S, French D, Tischkowitz M, Moorthie S, Walter F, et al.
Br J Cancer
. 2023 Feb;
128(9):1636-1646.
PMID: 36737659
In the UK, the National Institute for Health and Care Excellence (NICE) recommends that women at moderate or high risk of breast cancer be offered risk-reducing medication and enhanced breast...